Anticholinesterase

This MedLibrary.org supplementary page on Anticholinesterase is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

An acetylcholinesterase inhibitor or anti-cholinesterase is a chemical that inhibits the cholinesterase enzyme from breaking down acetylcholine, so increasing both the level and duration of action of the neurotransmitter acetylcholine.

Contents

Uses

Acetylcholinesterase inhibitors:

Examples

Reversible inhibitor

Compounds which function as reversible competitive or noncompetitive inhibitors of cholinesterase are those most likely to have therapeutic uses. These include:

Comparison table

Comparison of reversible acetylcholinesterase inhibitors
Inhibitor Duration1 Main site of action1 Clinical use1 Adverse effects1
Edrophonium short (10 min.) neuromuscular junction diagnosis of myasthenia gravis
Neostigmine medium (1-2 hrs.) neuromuscular junction visceral
Physiostigmine medium (0.5-5 hrs.) postganglionic parasympathetic treat glaucoma (eye drops)
Pyridostigmine medium (2-3 hrs.) neuromuscular junction
Dyflos long postganglionic parasympathetic historically to treat glaucoma (eye drops) toxic
Ecothiopate long postganglionic parasympathetic treat glaucoma (eye drops) systemic effects
Parathion (irreversible) long none toxic

Quasi-irreversible inhibitor

Compounds which function as quasi-irreversible inhibitors of cholinesterase are those most likely to have use as chemical weapons or pesticides. These include:

Natural Compounds

Effects

Some major effects of anticholinesterase inhibitors:

  • Actions on the autonomic nervous system, that is parasympathetic nervous system will cause bradycardia, hypotension, hypersecretion, bronchoconstriction, GI tract hypermotility, and decrease intraocular pressure.
  • SLUD syndrome.
  • Actions on the neuromuscular junction will result in prolonged muscle contraction.

Titration phase

When used in the central nervous system to alleviate neurological symptoms, such as rivastigmine in Alzheimer's disease, all cholinesterase inhibitors require doses to be increased gradually over several weeks, and this is usually referred to as the titration phase.2

See also

References

  1. ^ a b c d Unless else specified n boxes, then ref is:Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 156
  2. ^ Inglis F. “The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.” Int J Clin Pract. 2002;(127):45-63. PMID 12139367

External links

Wikipedia content modification information:

  • This page was last modified on 2 November 2008, at 18:20.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Anticholinesterase".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.